Recombinant Nanoarchaeum equitans Threonine--tRNA ligase (thrS), partial

Shipped with Ice Packs
In Stock

Description

Definition of Recombinant Nanoarchaeum equitans Threonine-tRNA Ligase (thrS), Partial

Recombinant Nanoarchaeum equitans Threonine-tRNA ligase (ThrRS), partial, refers to a genetically engineered form of the enzyme Threonine-tRNA ligase (ThrRS) derived from the archaeon Nanoarchaeum equitans, where only a fragment or a portion of the full-length enzyme is produced through recombinant DNA technology.

Nanoarchaeum equitans is a unique, tiny, hyperthermophilic archaeon with a minimal genome, known for its symbiotic relationship with Ignicoccus hospitalis . Due to its reduced genome, N. equitans possesses several fragmented genes and unusual RNA processing pathways, including the trans-splicing of tRNA halves for tRNA maturation .

RNA Processing and tRNA Splicing in Nanoarchaeum equitans

Nanoarchaeum equitans exhibits unique RNA processing mechanisms, including the trans-splicing of tRNA halves, to generate functional tRNA molecules . This process involves the joining of two separate tRNA half molecules to form a complete, mature tRNA .

  • The genome of N. equitans encodes tRNA halves, which, after trans-splicing, form intact tRNA molecules .

  • The tRNA sequences are split after the anticodon-adjacent position 37, which is the typical location for tRNA introns .

  • The tRNA half molecules contain sequences that facilitate the identification of matching halves, upon which the tRNA body folds .

  • A heterotetrameric splicing endonuclease and an RNA ligase work together to generate trans-spliced mature tRNAs .

Importance of Threonine-tRNA Ligase (ThrRS)

ThrRS plays a crucial role in maintaining the fidelity of protein synthesis by ensuring that threonine is correctly attached to its corresponding tRNA . The enzyme employs editing mechanisms to discriminate against similar amino acids, such as serine, and prevent mischarging of tRNA .

  • ThrRS has the ability to activate threonine and noncognate serine .

  • The archaeal ThrRS editing domains specifically and efficiently deacylate Ser-tRNA Thr, both in cis and trans .

  • The hydrolytic activity provided by the ThrRS editing domain is critical for protein synthesis quality control in vivo .

Editing Domain in Archaeal ThrRS

Archaeal ThrRSs, including the one from Nanoarchaeum equitans, possess distinct N-terminal domains responsible for the editing function . These domains are different from the editing domains found in bacterial and eukaryotic ThrRSs .

  • A distinct N-terminal domain present in the majority of archaeal ThrRSs performs the analogous editing function .

  • Some Crenarchaea, such as Sulfolobus solfataricus, have homologous domains that might perform the same function .

Tables

Table 1: Kinetic parameters for the activation of threonine and serine by ThrRS enzymes

EnzymeSubstrateKm (µM)kcat (s-1)
ThrRS-catThreonine124.2
ThrRS-catSerine2800.02
MJThrRSThreonine86.5
MJThrRSSerine1300.04

This table illustrates the specificity of ThrRS enzymes for threonine over serine, indicating the need for error correction mechanisms .

Table 2: tRNA half identification in N. equitans

tRNA HalfTermini Identified
tRNA-HisYes
tRNA-GluYes

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type will be determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
thrS; NEQ177; Threonine--tRNA ligase; EC 6.1.1.3; Threonyl-tRNA synthetase; ThrRS
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Nanoarchaeum equitans (strain Kin4-M)
Target Names
thrS
Uniprot No.

Target Background

Function
This protein catalyzes the attachment of threonine to tRNA(Thr) via a two-step reaction: L-threonine is first activated by ATP to form Thr-AMP, which is then transferred to the acceptor end of tRNA(Thr). It also functions as an editing enzyme, removing incorrectly charged L-seryl-tRNA(Thr).
Database Links

KEGG: neq:NEQ177

STRING: 228908.NEQ177

Protein Families
Class-II aminoacyl-tRNA synthetase family
Subcellular Location
Cytoplasm.

Q&A

What makes N. equitans tRNA processing unique compared to other organisms?

N. equitans exhibits extraordinary tRNA processing mechanisms that distinguish it from other organisms. Unlike conventional tRNA maturation pathways, N. equitans lacks RNase P, a nearly universal enzyme responsible for processing the 5′-leader sequence of precursor tRNAs. Instead, N. equitans' tRNAs are transcribed as leaderless tRNAs with 5′-triphosphate ends (ppp-tRNAs) . Additionally, five tRNA species in N. equitans are assembled from separate 5' and 3' halves that are transcribed from different parts of the genome, while four other tRNA species are derived from precursors containing introns . The tRNA sequences are typically split after the anticodon-adjacent position 37, which is the normal location of tRNA introns . This unique processing system likely evolved as an adaptation to the organism's parasitic lifestyle and extreme genome reduction.

How does the genomic organization of N. equitans impact tRNA ligase expression?

N. equitans possesses the smallest known archaeal genome (approximately 490 kb) with the highest coding density . This extreme genome compaction has led to a unique genomic organization where many essential genes, including those encoding tRNA ligases, may be split, shortened, or arranged in unusual operons. The tRNA genes themselves are often fragmented, with halves located in different regions of the genome . This organization likely impacts the expression of tRNA ligases like thrS, as these enzymes must function in a system where their substrates are produced through non-canonical pathways. Research indicates that N. equitans has adapted its genetic information processing to compensate for these constraints, possibly affecting the regulation and expression of aminoacyl-tRNA synthetases including threonine-tRNA ligase .

What is the relationship between N. equitans and its host I. hospitalis, and how might this affect tRNA ligase function?

N. equitans is an obligate symbiont or parasite that requires direct physical contact with its host, the hyperthermophilic archaeon Ignicoccus hospitalis, for survival . Proteomic studies have shown that I. hospitalis responds to N. equitans by reducing genetic information processing (replication, transcription) while enhancing energetic, protein processing, and cellular membrane functions . N. equitans appears to divert some of its host's metabolism and cell cycle control to compensate for its own metabolic shortcomings, being dependent on small, transferable metabolites and energetic precursors from I. hospitalis . This unique relationship may influence threonine-tRNA ligase function, as the enzyme must operate efficiently in an organism that relies on its host for many essential metabolites, potentially including threonine. The thermostability requirements of the enzyme are also significant, as both organisms thrive in hyperthermophilic conditions (70-98°C) .

What are the optimal expression systems for producing recombinant N. equitans threonine-tRNA ligase?

The expression of recombinant N. equitans threonine-tRNA ligase presents unique challenges due to the hyperthermophilic nature of the source organism and potential folding issues in mesophilic expression hosts. Based on successful approaches with other N. equitans proteins, the following expression systems are recommended:

Expression SystemAdvantagesChallengesOptimal Conditions
E. coli BL21(DE3) with pET vectorsHigh yield, well-established protocolsPotential misfolding of hyperthermophilic proteinsInduction at lower temperatures (15-18°C), inclusion of chaperones (GroEL/ES)
E. coli Rosetta strainsAccommodation of rare codons found in archaeal genesSimilar to standard E. coli challengesSupplementation with rare tRNAs, moderate expression temperature
Sulfolobus systemsNative-like folding environment for thermophilic proteinsLower yields, more complex culturingHigher expression temperature (60-75°C), specific induction methods
Cell-free systemsAvoids toxicity issues, rapid productionHigher cost, optimization requiredSupplementation with thermostable components, post-translation thermal stabilization

When expressing the recombinant threonine-tRNA ligase, adding a C-terminal polyhistidine tag generally allows efficient purification while minimizing interference with the catalytic activity of the enzyme. For optimal activity assessment, purification should include a heat treatment step (70-80°C) to remove thermolabile host proteins, followed by nickel affinity chromatography and size exclusion chromatography .

How should researchers address the thermostability requirements when working with recombinant N. equitans thrS?

Working with recombinant N. equitans threonine-tRNA ligase requires specific considerations for thermostability throughout the experimental workflow:

  • Buffer Optimization: Use buffers with higher thermostability such as HEPES or PIPES rather than Tris-based buffers which have significant temperature coefficients. Buffer compositions should typically include:

    • 50 mM HEPES or PIPES, pH 7.5 (measured at the working temperature)

    • 300-500 mM NaCl or KCl for ionic strength

    • 5-10 mM MgCl₂ for divalent cation requirements

    • 1-2 mM DTT or TCEP as reducing agents

    • 10% glycerol as a stabilizing agent

  • Purification Strategy: Initial capture of the recombinant protein should be performed at moderate temperatures (25-30°C), followed by a controlled heat treatment step (75-85°C for 15-30 minutes) to exploit the thermostability of the target protein and remove host contaminants. This approach leverages the natural thermophilicity of the enzyme as a purification advantage .

  • Storage Conditions: Purified enzyme should be stored in buffers containing thermostabilizing agents such as trehalose or glycerol (15-20%). Short-term storage is recommended at 4°C, while long-term storage should be at -80°C with flash freezing in liquid nitrogen to prevent damage from ice crystal formation.

  • Activity Assays: All enzymatic assays should be conducted at temperatures that reflect the physiological conditions of N. equitans (optimally 80-95°C). This requires specialized equipment such as thermal cyclers or heat blocks with precise temperature control and sealed reaction vessels to prevent evaporation .

What are the methodological approaches for assessing the aminoacylation activity of recombinant N. equitans thrS?

Several complementary approaches can be employed to assess the aminoacylation activity of recombinant N. equitans threonine-tRNA ligase:

  • Radiolabeled Amino Acid Incorporation Assay:

    • Incubate the recombinant thrS with [³H] or [¹⁴C]-labeled threonine, ATP, and its cognate tRNA at optimal temperature (80-90°C)

    • After reaction, precipitate tRNA with trichloroacetic acid on filter papers

    • Wash thoroughly to remove unincorporated label

    • Measure radioactivity using scintillation counting

    • Calculate aminoacylation rates under various conditions (temperature, pH, salt)

  • Thin Layer Chromatography (TLC) Assay:

    • React thrS with tRNA and [³²P]-labeled ATP

    • Separate the AMP byproduct by TLC

    • Quantify the reaction progress through phosphorimaging

  • Pyrophosphate Exchange Assay:

    • Monitor the ATP-pyrophosphate exchange as an indirect measurement of amino acid activation

    • Particularly useful for studying the first step of the aminoacylation reaction

    • Can be performed with [³²P]-labeled pyrophosphate

  • Mass Spectrometry-Based Approach:

    • Analyze the mass shift of tRNA before and after aminoacylation

    • Provides direct evidence of threonyl-tRNA formation without radiolabeling

    • Requires precise instrumentation and sample preparation

The choice between these methods depends on the specific research question, with the radiolabeled approach offering the highest sensitivity for kinetic studies, while the mass spectrometry approach provides the most direct evidence of aminoacylation .

How does the structure of N. equitans threonine-tRNA ligase compare to that of other organisms, and what are the implications for function?

N. equitans threonine-tRNA ligase exhibits several structural adaptations that reflect both its hyperthermophilic nature and the unique evolutionary pressures of its parasitic lifestyle. Comparative structural analysis reveals:

These structural features have significant functional implications, including enhanced thermostability, potentially altered specificity parameters, and adaptation to the cellular environment of a parasitic organism with a reduced genome. The compact nature of the enzyme may also reflect the genome minimization pressure evident throughout N. equitans evolution .

What specific adaptations does N. equitans thrS show for functioning in hyperthermophilic conditions?

N. equitans threonine-tRNA ligase exhibits several specific adaptations for functioning at extremely high temperatures (70-98°C):

  • Amino Acid Composition Bias:

    • Increased proportion of charged residues (Lys, Arg, Glu)

    • Higher hydrophobic content in the protein core

    • Reduction in thermolabile residues (Asn, Gln)

    • Preference for shorter side chain residues in surface loops

    This composition pattern is consistent with observations in other N. equitans proteins that show systematic replacement of uncharged polar residues with charged residues compared to mesophilic homologs .

  • Structural Stabilization Mechanisms:

    • Increased number of salt bridges and ion pairs

    • Enhanced hydrophobic packing in the protein core

    • Additional disulfide bridges for covalent stabilization

    • Shortened surface loops to reduce flexibility at high temperatures

  • Kinetic and Thermodynamic Properties:

    • Optimal activity at temperatures above 80°C

    • Reduced activity at mesophilic temperatures (20-37°C)

    • Higher activation energy for the aminoacylation reaction

    • Significantly higher melting temperature (Tm > 90°C)

These adaptations allow N. equitans thrS to maintain structural integrity and catalytic function under conditions that would rapidly denature most proteins from mesophilic organisms, enabling essential aminoacylation activity in the hyperthermophilic environment where N. equitans and its host thrive .

How does N. equitans thrS recognize and process its cognate tRNA given the unique tRNA features in this organism?

The recognition and processing of tRNA^Thr by N. equitans threonine-tRNA ligase involves several specialized mechanisms to accommodate the unique features of N. equitans tRNAs:

These recognition mechanisms represent adaptations to the unique combination of hyperthermophily and genomic reduction that characterizes N. equitans biology .

What are the main challenges in producing active recombinant N. equitans tRNA for thrS activity studies?

Producing active recombinant N. equitans tRNA^Thr for threonine-tRNA ligase activity studies presents several significant challenges:

  • Correct Processing of tRNA Ends:

    • Challenge: N. equitans lacks RNase P and produces leaderless tRNAs with 5'-triphosphate ends . In vitro transcribed tRNAs typically have 5'-triphosphate ends, but studies with other N. equitans tRNAs show preference for 5'-monophosphorylated forms.

    • Solution: Prepare both 5'-triphosphorylated tRNAs (direct transcription) and 5'-monophosphorylated variants (using RNA 5' polyphosphatase treatment) to determine optimal substrates for thrS. Comparative aminoacylation assays with both forms will identify substrate preferences.

  • Proper Folding at High Temperatures:

    • Challenge: N. equitans tRNAs must fold correctly at hyperthermophilic temperatures (70-98°C), which can affect base pairing stability.

    • Solution: Implement temperature-controlled refolding protocols involving slow cooling from high temperatures (95°C) in the presence of magnesium ions (5-10 mM MgCl₂). Verify folding using thermal denaturation profiles and structure-probing techniques.

  • Handling Split tRNA Genes:

    • Challenge: If tRNA^Thr is encoded by split genes, separate transcription and joining of the halves is required.

    • Solution: Identify if tRNA^Thr is split based on genomic analysis. If split, separately transcribe the 5' and 3' halves and join them through either enzymatic trans-splicing (using purified N. equitans splicing endonuclease) or chemical ligation methods .

  • Post-transcriptional Modifications:

    • Challenge: Native tRNAs contain numerous modifications crucial for proper structure and function.

    • Solution: For initial studies, use unmodified in vitro transcripts. For more comprehensive analyses, consider partial modification systems or compare with native tRNAs isolated from N. equitans cultures (though this is challenging due to their obligate parasitic nature).

By systematically addressing these challenges, researchers can produce functional tRNA substrates that closely mimic the native tRNAs encountered by thrS in vivo .

How can researchers overcome the difficulties of studying an enzyme from an obligate symbiont that requires extreme cultivation conditions?

Studying enzymes from N. equitans presents unique challenges due to its obligate symbiotic relationship with I. hospitalis and the extreme cultivation conditions required. Researchers can employ the following strategies to overcome these difficulties:

  • Heterologous Expression Systems:

    • Use E. coli or other tractable hosts with codon-optimized synthetic genes for N. equitans thrS

    • Employ specialized vectors containing thermostable chaperones to assist proper folding

    • Consider archaeal expression systems (such as Thermococcus or Sulfolobus) for proteins that fail to express in bacterial systems

  • Co-culture Systems and Native Protein Isolation:

    • Establish laboratory co-cultures of N. equitans and I. hospitalis using specialized bioreactors

    • Implement careful cell separation techniques (such as filtration or density gradient centrifugation)

    • Use proteomics approaches to identify and characterize native thrS from mixed cultures

    • Develop mild extraction procedures that preserve enzyme activity while separating N. equitans proteins

  • Computational and Structural Biology Approaches:

    • Utilize homology modeling based on related threonine-tRNA ligases

    • Apply molecular dynamics simulations under high-temperature conditions

    • Design experimental work based on in silico predictions of critical residues and domains

  • Functional Complementation Studies:

    • Test N. equitans thrS function in vivo through genetic complementation in tractable thermophilic archaea

    • Develop conditional expression systems in mesophilic hosts that can be shifted to higher temperatures for activity assays

  • Synthetic Biology Approaches:

    • Reconstruct minimal systems containing recombinant thrS and in vitro transcribed tRNAs

    • Design cell-free translation systems optimized for high-temperature function

By combining these approaches, researchers can study N. equitans thrS without necessarily requiring the challenging native cultivation conditions of this unique archaeal symbiont .

What experimental controls and validations are essential when studying recombinant N. equitans thrS?

Rigorous experimental controls and validations are essential when studying recombinant N. equitans threonine-tRNA ligase to ensure reliable and reproducible results:

  • Expression and Purification Validations:

    • SDS-PAGE analysis with Coomassie staining to verify size and purity

    • Western blot confirmation using anti-His tag antibodies (if His-tagged)

    • Mass spectrometry verification of protein identity and integrity

    • Size exclusion chromatography to confirm monomeric/oligomeric state

    • Thermal shift assays to verify proper folding and thermostability

  • Enzymatic Activity Controls:

    • Negative controls lacking ATP, threonine, or tRNA to verify reaction specificity

    • Heat-inactivated enzyme controls (pre-treatment at 100°C+ for extended periods)

    • Temperature-dependent activity profile (20-100°C range) to confirm thermophilic character

    • Comparative assays with threonine-tRNA ligases from mesophilic sources

    • Substrate specificity controls (non-cognate amino acids and tRNAs)

  • tRNA Substrate Validations:

    • Gel electrophoresis under native and denaturing conditions to verify tRNA integrity

    • Thermal melting profiles to confirm proper folding

    • End-group analysis to verify 5'-phosphorylation status

    • Aminoacylation tests with well-characterized aminoacyl-tRNA synthetases

  • Thermostability Verifications:

    • Circular dichroism spectroscopy at various temperatures

    • Differential scanning calorimetry to determine melting temperatures

    • Activity retention tests after high-temperature incubations

    • Long-term stability assessment at storage conditions

  • Specificity Validations:

    • Cross-aminoacylation tests with related amino acids (serine, valine)

    • Mutation of key residues in thrS to confirm critical functional sites

    • Competition assays with cognate and non-cognate substrates

These controls help distinguish genuine N. equitans thrS activity from artifacts and ensure that the recombinant enzyme faithfully represents the native enzyme's properties .

How has the unique genomic configuration of N. equitans influenced the evolution of its aminoacyl-tRNA synthetases?

The extreme genome reduction and unique genomic architecture of N. equitans have profoundly influenced the evolution of its aminoacyl-tRNA synthetases (aaRSs), including threonine-tRNA ligase:

This unique evolutionary context provides valuable insights into the minimal functional requirements of aminoacyl-tRNA synthetases and their adaptability to extreme genomic and environmental constraints .

What insights might N. equitans thrS provide about the co-evolution of aminoacyl-tRNA synthetases and their tRNA substrates?

N. equitans threonine-tRNA ligase offers a unique window into the co-evolutionary dynamics between aminoacyl-tRNA synthetases and their tRNA substrates, particularly in the context of extreme genome reduction and unusual tRNA gene structures:

  • Identity Element Evolution: The recognition of tRNA^Thr by thrS depends on specific identity elements. In N. equitans, the conservation or modification of these elements in the context of split tRNAs and trans-splicing mechanisms provides insights into which features are absolutely essential for recognition versus those that can be modified through co-evolutionary processes.

  • Adaptation to Non-Canonical tRNA Structures: N. equitans thrS must function with tRNAs that may have unusual structural features resulting from trans-splicing or unique maturation pathways in the absence of RNase P . This adaptation demonstrates the plasticity of aminoacyl-tRNA synthetase recognition mechanisms and their ability to accommodate structural variations in their tRNA substrates.

  • Phosphorylation State Preferences: Studies with other N. equitans tRNAs (like tRNA^His) show preferences for 5'-monophosphorylated forms over 5'-triphosphorylated forms . This preference in the context of leaderless tRNA transcription suggests co-evolutionary adaptations in both the tRNA processing pathway and the aminoacyl-tRNA synthetases that must function in this unusual system.

  • Minimalist Recognition Systems: The extreme genome reduction in N. equitans suggests that its tRNA-aminoacyl-tRNA synthetase recognition systems may represent near-minimal configurations that maintain specificity and efficiency. This provides insights into the core elements required for these interactions across all domains of life.

  • Impact of Thermophily on Co-evolution: The hyperthermophilic nature of N. equitans adds another dimension to the co-evolutionary process, as both the tRNAs and aminoacyl-tRNA synthetases must maintain their interactions at extremely high temperatures. This has likely driven coordinated adaptations in both partners to ensure stable yet dynamic interactions under these challenging conditions.

These co-evolutionary insights from N. equitans thrS and its tRNA substrates contribute to our fundamental understanding of the evolution of translation systems and their adaptability to extreme conditions and genomic constraints .

What methodological approaches can be used to study the potential role of N. equitans thrS in the symbiotic relationship with its host?

Investigating the potential role of N. equitans threonine-tRNA ligase in the symbiotic relationship with I. hospitalis requires integrative methodological approaches that span from molecular to cellular levels:

  • Comparative Expression Analysis:

    • Implement RNA-seq to quantify thrS expression levels under different co-culture conditions

    • Use quantitative proteomics to determine thrS protein abundance in various growth phases

    • Compare expression patterns with other aminoacyl-tRNA synthetases to identify differential regulation

    • Correlate expression with key metabolic markers in both organisms

  • Protein Localization Studies:

    • Develop fluorescent protein fusions or specific antibodies against N. equitans thrS

    • Employ immunoelectron microscopy to determine subcellular localization

    • Investigate potential localization at the interface between N. equitans and I. hospitalis

    • Examine co-localization with other components of the translation machinery

  • Metabolic Interaction Analysis:

    • Trace threonine metabolism using isotope-labeled precursors

    • Monitor potential threonine or threonyl-tRNA transfer between the organisms

    • Implement metabolic flux analysis focusing on amino acid exchange patterns

    • Examine effects of threonine limitation on the symbiotic relationship

  • Protein-Protein Interaction Studies:

    • Use pull-down assays with tagged thrS to identify potential interacting partners

    • Apply crosslinking mass spectrometry to capture transient interactions

    • Investigate potential interactions with I. hospitalis membrane or transport proteins

    • Employ bacterial two-hybrid systems adapted for thermophilic proteins

  • Functional Inhibition Approaches:

    • Design specific inhibitors of N. equitans thrS based on structural information

    • Test the impact of inhibition on N. equitans survival and replication

    • Examine effects on I. hospitalis physiology when the symbiont's thrS is inhibited

    • Use inducible antisense RNA systems to modulate thrS expression

These methodological approaches can provide complementary insights into whether thrS plays a specific role in the symbiotic relationship or simply functions as an essential housekeeping enzyme for N. equitans protein synthesis. Proteomic studies have shown that I. hospitalis reacts to N. equitans by curtailing genetic information processing while intensifying energetic and protein processing functions, suggesting complex metabolic interactions between the two organisms . Understanding thrS in this context could reveal important aspects of the molecular basis for this unique symbiotic relationship.

What are the most common technical challenges when expressing and purifying recombinant N. equitans thrS, and how can they be addressed?

Researchers working with recombinant N. equitans threonine-tRNA ligase frequently encounter several technical challenges. The following troubleshooting guide addresses these issues with practical solutions:

ChallengePossible CausesSolutions
Low expression yields- Codon bias incompatibility
- Toxicity to host
- Protein instability at expression temperature
- Use codon-optimized synthetic gene
- Switch to tightly regulated expression systems (pET with T7-lysozyme)
- Express at lower temperatures (15-18°C)
- Add stabilizing agents (sorbitol, betaine) to growth media
Insoluble protein/inclusion bodies- Improper folding in mesophilic host
- Hydrophobic regions exposure
- Disulfide formation issues
- Co-express with thermophilic chaperones
- Use solubility-enhancing fusion tags (SUMO, MBP)
- Implement on-column refolding protocols
- Optimize lysis buffer with mild detergents
Loss of activity during purification- Oxidation of critical cysteines
- Removal of essential metal cofactors
- Proteolytic degradation
- Maintain reducing conditions throughout purification
- Include appropriate metal ions (Zn²⁺, Mg²⁺)
- Add protease inhibitors and work at 4°C
- Consider rapid purification protocols
Inconsistent enzymatic activity- Batch-to-batch variation
- Incomplete reaction conditions
- Unstable tRNA substrate
- Standardize expression and purification protocols
- Ensure complete buffer components (especially ATP, Mg²⁺)
- Verify tRNA folding before each assay
- Implement internal standards for activity normalization
Limited thermostability after purification- Destabilization during buffer exchanges
- Loss of stabilizing interactions
- Add osmolytes or compatible solutes (trehalose, glycerol)
- Maintain higher salt concentrations (300-500 mM)
- Optimize storage buffer through thermal shift assays

Successful expression often requires combining multiple approaches. For example, researchers might use an E. coli Rosetta strain (addressing codon bias) with a pET-SUMO vector (enhancing solubility) while culturing at reduced temperatures with osmolyte supplementation. This multi-faceted approach typically yields better results than addressing single factors sequentially .

How can researchers accurately determine the kinetic parameters of N. equitans thrS under thermophilic conditions?

Determining accurate kinetic parameters for N. equitans threonine-tRNA ligase under thermophilic conditions requires specialized approaches to address the challenges of high-temperature enzymatic assays:

  • Optimized High-Temperature Reaction Setup:

    • Use sealed PCR tubes or specialized high-pressure reaction vessels to prevent evaporation

    • Implement temperature-controlled water baths or thermocyclers with high precision (±0.5°C)

    • Pre-equilibrate all components (buffers, substrates, enzyme) separately before initiating reactions

    • Include internal temperature sensors to verify actual reaction temperatures

  • Rapid Sampling Techniques:

    • Develop quenching methods that instantly stop the reaction (e.g., liquid nitrogen freezing or acidic conditions)

    • Use automated sampling devices when possible to ensure precision

    • Implement time-course measurements with very short intervals for initial velocity determinations

    • Consider continuous assay formats where applicable (e.g., coupled enzyme assays with thermostable coupling enzymes)

  • Substrate Stability Considerations:

    • Verify ATP stability at reaction temperatures (typically degrades rapidly above 80°C)

    • Freshly prepare tRNA substrates and verify their integrity after exposure to reaction temperatures

    • Implement controls that account for thermal degradation of substrates

    • Consider substrate replenishment strategies for longer reactions

  • Data Analysis Adaptations:

    • Apply Arrhenius plot analysis to characterize temperature dependence

    • Use integrated rate equations rather than initial velocity for reactions where substrate depletion is significant

    • Implement global fitting approaches that simultaneously analyze multiple datasets

    • Correct for background thermal effects on assay components

  • Specialized Kinetic Models:

    • Consider non-Michaelis-Menten kinetics that may be more appropriate for thermophilic enzymes

    • Implement models that account for temperature effects on binding constants

    • Analyze product inhibition carefully, as it may be more significant at high temperatures

    • Develop models that incorporate enzyme stability factors at reaction temperatures

By implementing these specialized approaches, researchers can obtain reliable kinetic parameters (KM, kcat, specificity constants) that accurately reflect the true catalytic properties of N. equitans thrS under physiologically relevant conditions .

What approaches can be used to investigate the substrate specificity of N. equitans thrS?

Investigating the substrate specificity of N. equitans threonine-tRNA ligase requires multifaceted approaches that examine both amino acid and tRNA recognition:

  • Amino Acid Specificity Assays:

    • ATP-PPi Exchange Assay: Measure the activation of various amino acids (threonine, serine, valine) through ATP-pyrophosphate exchange at high temperatures

    • Misaminoacylation Analysis: Test charging of tRNA^Thr with non-cognate amino acids under various conditions

    • Competitive Inhibition Studies: Determine Ki values for threonine analogs and structurally related amino acids

    • Pre-transfer Editing Analysis: Examine hydrolysis of misactivated aminoacyl-adenylates using thin-layer chromatography

  • tRNA Recognition Investigations:

    • Variant tRNA Library Screening: Systematically modify potential identity elements in tRNA^Thr and assess aminoacylation efficiency

    • Chimeric tRNA Assays: Create hybrid tRNAs with elements from tRNA^Thr and other tRNAs to identify critical recognition regions

    • In vitro Selection (SELEX): Identify preferred RNA sequences and structures through iterative selection from randomized tRNA libraries

    • Cross-species tRNA Testing: Examine aminoacylation of tRNA^Thr from different organisms to assess conservation of recognition elements

  • Structural Biology Approaches:

    • Molecular Docking: Computational modeling of thrS-tRNA and thrS-amino acid interactions

    • Cryo-EM Analysis: Structural characterization of thrS-tRNA complexes under near-physiological conditions

    • Hydrogen-Deuterium Exchange Mass Spectrometry: Identify regions of conformational change upon substrate binding

    • X-ray Crystallography: Determine atomic-resolution structures of thrS with various ligands (when feasible)

  • Mutagenesis Strategies:

    • Alanine Scanning: Systematically replace predicted substrate-binding residues

    • Domain Swapping: Exchange recognition domains between thrS and other aminoacyl-tRNA synthetases

    • Rational Design: Introduce mutations predicted to alter specificity based on structural models

    • Directed Evolution: Develop high-throughput screens to select thrS variants with altered specificity

These complementary approaches can provide comprehensive insights into the molecular basis of substrate recognition by N. equitans thrS, potentially revealing adaptations related to the organism's unique lifestyle and evolutionary history .

What are the most promising future research directions for understanding N. equitans thrS in the context of minimal translation systems?

Investigation of N. equitans threonine-tRNA ligase offers several promising research directions that could enhance our understanding of minimal translation systems:

  • Minimal Functional Domain Analysis:

    • Systematic truncation studies to identify the minimal thrS architecture that retains function

    • Characterization of domain interfaces and their contributions to catalysis and stability

    • Computational modeling to predict minimal configurations that maintain amino acid specificity

    • Comparison with thrS from free-living organisms to identify dispensable structural elements

  • Synthetic Biology Applications:

    • Development of thermostable minimal translation systems incorporating N. equitans thrS

    • Creation of orthogonal translation systems for incorporation of non-canonical amino acids

    • Design of minimal synthetic cells with streamlined aminoacylation machinery

    • Engineering thermostable biosensors based on thrS specificity mechanisms

  • Evolutionary Model Systems:

    • Reconstruction of ancestral thrS sequences to trace evolutionary pathways to minimization

    • Experimental evolution to identify compensatory adaptations to further thrS simplification

    • Comparative studies across diverse symbiotic/parasitic systems with genome reduction

    • Testing hypotheses about the origins of genetic code expansion/contraction

  • Structural Adaptations to Split tRNA Recognition:

    • Detailed characterization of how thrS recognizes mature tRNAs derived from split genes

    • Investigation of potential specialized domains for handling trans-spliced tRNAs

    • Analysis of adaptation to the absence of RNase P and leaderless tRNA processing

    • Structural comparisons with thrS enzymes from organisms with conventional tRNA processing

  • Systems Biology Integration:

    • Modeling of thrS function within the context of N. equitans' minimal proteome

    • Network analysis of genetic interactions and functional dependencies

    • Investigation of regulatory mechanisms in minimal translation systems

    • Quantitative assessment of translation efficiency with minimal aminoacylation components

These research directions leverage the unique properties of N. equitans thrS as a model for understanding fundamental aspects of translation systems operating under extreme constraints of genome minimization and thermophilic conditions .

How might research on N. equitans thrS contribute to the development of novel biotechnological applications?

Research on N. equitans threonine-tRNA ligase offers several promising avenues for biotechnological innovation:

  • Thermostable Biocatalysts for Protein Engineering:

    • Development of heat-resistant in vitro translation systems for protein expression at elevated temperatures

    • Creation of enzymatic cascades incorporating thermostable aminoacyl-tRNA synthetases for industrial biocatalysis

    • Engineering of N. equitans thrS variants with expanded substrate specificity for incorporation of non-canonical amino acids

    • Design of robust cell-free protein synthesis platforms optimized for harsh conditions

  • Therapeutic and Diagnostic Applications:

    • Exploitation of structural differences between archaeal and human thrS for development of selective antimicrobials

    • Creation of stable protein-based biosensors for threonine detection in clinical samples

    • Development of novel thermostable molecular tools for CRISPR-based technologies

    • Design of heat-resistant enzymatic assays for point-of-care diagnostics in resource-limited settings

  • Synthetic Biology Platforms:

    • Integration of N. equitans thrS into minimal synthetic cells with reduced genome complexity

    • Development of orthogonal translation systems for biocontainment applications

    • Creation of temperature-inducible gene expression systems based on thermostable components

    • Design of robust genetic circuits that can function across broad temperature ranges

  • Protein Stabilization Technologies:

    • Analysis of N. equitans thrS thermostabilization mechanisms for application to protein engineering

    • Development of computational algorithms for predicting thermostabilizing mutations in industrial enzymes

    • Creation of chimeric proteins incorporating thermostable domains from N. equitans proteins

    • Design of novel protein scaffolds based on the structural core of thermostable aminoacyl-tRNA synthetases

  • Bioinformatics and Computational Tools:

    • Development of improved algorithms for predicting protein-RNA interactions based on N. equitans thrS-tRNA recognition

    • Creation of new tools for identifying minimal functional domains in complex proteins

    • Design of software for predicting thermal stability based on thermophilic protein datasets

    • Implementation of machine learning approaches for protein design using extremophile data

These biotechnological applications leverage the unique properties of N. equitans thrS, particularly its extreme thermostability, specificity mechanisms, and adaptation to a minimal cellular context .

What interdisciplinary approaches could advance our understanding of the unique biology of N. equitans through the study of its thrS?

Advancing our understanding of N. equitans biology through the study of its threonine-tRNA ligase requires innovative interdisciplinary approaches that bridge multiple scientific domains:

  • Integrative Structural Biology:

    • Combine cryo-electron microscopy, X-ray crystallography, and NMR spectroscopy to characterize thrS structure

    • Implement hydrogen-deuterium exchange mass spectrometry to map dynamic aspects of enzyme function

    • Apply molecular dynamics simulations calibrated with experimental data to predict behavior at extreme temperatures

    • Develop integrative computational models incorporating multiple experimental datasets

  • Systems Biology and Bioinformatics:

    • Construct network models of N. equitans translation machinery to contextualize thrS function

    • Apply machine learning to identify subtle patterns in genome organization and expression

    • Develop specialized comparative genomics tools for extremely reduced genomes

    • Implement flux balance analysis to model the metabolic interdependencies between N. equitans and its host

  • Evolutionary Biochemistry and Synthetic Biology:

    • Reconstruct ancestral thrS sequences to trace the evolutionary path to genome minimization

    • Design minimal synthetic cells incorporating N. equitans translation components

    • Test hypotheses about co-evolution of synthetases and tRNAs through experimental evolution

    • Engineer chimeric translation systems to identify essential components

  • Advanced Imaging and Single-Molecule Approaches:

    • Apply super-resolution microscopy to visualize thrS localization in N. equitans cells

    • Implement single-molecule FRET to characterize thrS-tRNA interactions in real-time

    • Use atomic force microscopy to examine structural dynamics under varying conditions

    • Develop in vivo labeling strategies to track thrS activity in the context of the host-symbiont interface

  • Astrobiology and Origin of Life Research:

    • Examine thrS as a model for early translation system components in extreme environments

    • Investigate the minimal requirements for functional aminoacylation in prebiotic scenarios

    • Test hypotheses about thermophilic origins of life using N. equitans components as models

    • Explore implications for potential extraterrestrial life in extreme environments

  • Multi-omics Integration:

    • Combine proteomics, transcriptomics, and metabolomics to create comprehensive models of N. equitans physiology

    • Implement parallel reaction monitoring to quantify absolute abundances of translation components

    • Apply spatial metabolomics to characterize metabolite exchange at the host-symbiont interface

    • Develop specialized computational pipelines for integrating multi-omics data from minimal genomes

These interdisciplinary approaches can provide unprecedented insights into how N. equitans thrS functions within the context of an extremely reduced genome, extreme thermophily, and obligate symbiosis with a host organism .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.